GEMINI
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects with ACS
- Stage
- klaar
- Medicine
- rivaroxaban
- Population
- ASCVD
- Phase
- II
- First Patient In
- 15 May 2015
- Last Patient In
- 23 February 2016
- Last Patient Last Visit
- 23 August 2016
National Lead
prof. dr. J.H. Cornel
Cardioloog
Study Director
